Accelerant to Be Acquired by Thoma Bravo for $20.25/Share; Q2 Earnings Beat, Guidance Pulled
ARX has more than doubled off its 52-week low of $9.18.
Summary
Accelerant Holdings agreed to be acquired by Thoma Bravo for $20.25 per share in cash, a 49% premium. The filing also includes strong Q2 earnings, but guidance was withdrawn and the earnings call canceled.
Key Events · M&A and Partnerships · ARX
-
Thoma Bravo Acquisition at 49% Premium
Accelerant agreed to be acquired by Thoma Bravo for $20.25 per share in cash, a 49% premium to the August 12 close, valuing the company at over $4 billion enterprise value.
-
Q2 Earnings Beat with Strong Growth
Exchange Written Premium grew 23% YoY to $1.32 billion; adjusted EBITDA rose 46% to $93.1 million with a 30.6% margin; adjusted net income increased 165% to $70 million.
-
Guidance Withdrawn, Call Canceled
Due to the pending transaction, Accelerant canceled its earnings conference call and will not provide Q3 or full-year 2026 guidance.
-
Voting Support from Altamont
Altamont Capital Partners, holding approximately 82% of outstanding voting rights, has agreed to vote in favor of the transaction, making shareholder approval highly likely.
Analysis · ARX · Finance
Accelerant Holdings agreed to be acquired by Thoma Bravo for $20.25 per share in cash, a 49% premium to the August 12 close. The deal values the company at over $4 billion enterprise value and is expected to close in the first half of 2027, subject to shareholder and regulatory approvals. Altamont Capital Partners, holding approximately 82% of voting rights, has agreed to vote in favor, making approval highly likely. The filing also includes Q2 results showing strong growth — exchange written premium up 23% to $1.32 billion, adjusted EBITDA up 46% to $93.1 million — but the company withdrew guidance and canceled its earnings call due to the pending transaction. A 6% per annum ticking fee applies if closing is delayed by insurance regulatory approvals. This is a thesis-altering event: shareholders will receive a substantial premium, and the company will be delisted upon completion.
At the time of this filing, ARX was trading at $19.74 on NYSE in the Finance sector, with a market capitalization of approximately $3B. The 52-week trading range was $9.18 to $30.48. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.